Last updated: 30 August 2024 at 5:16pm EST

John Dineen Net Worth




The estimated Net Worth of John M. Dineen is at least $454 Thousand dollars as of 13 November 2023. Mr. Dineen owns over 1,827 units of Syneos Health Inc stock worth over $78,524 and over the last 9 years he sold SYNH stock worth over $0. In addition, he makes $375,000 as Independent Chairman of the Board at Syneos Health Inc.

Mr. Dineen SYNH stock SEC Form 4 insiders trading

John has made over 3 trades of the Syneos Health Inc stock since 2015, according to the Form 4 filled with the SEC. Most recently he exercised 1,827 units of SYNH stock worth $108,743 on 13 November 2023.

The largest trade he's ever made was buying 100,000 units of Syneos Health Inc stock on 12 August 2015 worth over $1,015,000. On average, John trades about 3,454 units every 94 days since 2015. As of 13 November 2023 he still owns at least 1,827 units of Syneos Health Inc stock.

You can see the complete history of Mr. Dineen stock trades at the bottom of the page.





John Dineen biography

John M. Dineen serves as Independent Chairman of the Board of the Company. He was appointed as the independent Chairman of the Board of Syneos Health in December 2018. Mr. Dineen brings to the role more than 30 years of healthcare, technology and international management experience, most recently serving as Chief Executive Officer of GE’s Healthcare business from 2008 to 2014. Previously, Mr. Dineen spent more than two decades in a variety of other global leadership positions within GE, including President and Chief Executive Officer of GE Transportation, President of GE Plastics, General Manager of GE’s Power Equipment business, and General Manager of GE’s Appliances, Microwave and Air-Conditioning businesses. Since 2015, Mr. Dineen has served as an operating advisor of the investment firm Clayton, Dubilier & Rice LLC. He also currently serves on the board of directors of Cognizant Technology Solutions Corporation (Nasdaq:CTSH), a leading provider of information technology, consulting, and business process services, where he serves on the Finance and Strategy Committee and Nominating, Governance and Public Affairs Committee. He also currently serves as the chairman of the board of directors of Healogics and Carestream Dental. Mr. Dineen received Bachelor’s degrees in Biology and Computer Science from the University of Vermont where he now serves on the board of trustees.

What is the salary of John Dineen?

As the Independent Chairman of the Board of Syneos Health Inc, the total compensation of John Dineen at Syneos Health Inc is $375,000. There are 10 executives at Syneos Health Inc getting paid more, with Alistair Macdonald having the highest compensation of $7,646,360.



How old is John Dineen?

John Dineen is 57, he's been the Independent Chairman of the Board of Syneos Health Inc since 2018. There are 4 older and 17 younger executives at Syneos Health Inc. The oldest executive at Syneos Health Inc is William Klitgaard, 67, who is the Independent Director.

Insiders trading at Syneos Health Inc

Over the last 7 years, insiders at Syneos Health Inc have traded over $16,280,601,287 worth of Syneos Health Inc stock and bought 17,946 units worth $873,496 . The most active insiders traders include Todd M Abbrecht, John L. Maldonado, and Tom Allen. On average, Syneos Health Inc executives and independent directors trade stock every 14 days with the average trade being worth of $83,067,962. The most recent stock trade was executed by Michael Lee Brooks on 28 July 2022, trading 1,502 units of SYNH stock currently worth $117,156.



What does Syneos Health Inc do?

inc research/inventiv health has become syneos health, the only fully integrated end-to-end clinical and commercial solution organization. we are purpose-built for biopharmaceutical acceleration, creating better, smarter, faster ways to help clients navigate an increasingly complex marketplace. our new business addresses today’s market realities through clinical and commercial sharing expertise and data and insights to meet the needs of emerging and large global biopharmaceutical companies.



Complete history of Mr. Dineen stock trades at Cognizant Technology Solutions, Lam Research, Merrimack Pharmaceuticals Inc, and Syneos Health Inc

Insider
Trans.
Transaction
Total value
John M. Dineen
Director
Option $108,743
13 Nov 2023
John M. Dineen
Director
Buy $513,725
6 Jul 2020
John M. Dineen
Director
Buy $1,015,000
12 Aug 2015


Syneos Health Inc executives and stock owners

Syneos Health Inc executives and other stock owners filed with the SEC include: